Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
30 hedge funds and large institutions have $23.7M invested in Vicarious Surgical in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 8 increasing their positions, 5 reducing their positions, and 6 closing their positions.
126% more capital invested
Capital invested by funds: $10.4M → $23.7M (+$13.2M)
60% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 5
0.88% less ownership
Funds ownership: 35.11% → 34.23% (-0.88%)
12% less funds holding
Funds holding: 34 → 30 (-4)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DnB Asset Management
Oslo,
Norway
|
+$38K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$24K |
| 3 |
JP Morgan Chase
New York
|
+$21K |
| 4 |
Morgan Stanley
New York
|
+$17.9K |
| 5 |
Renaissance Technologies
New York
|
+$12.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DP
DDD Partners
Bellevue,
Washington
|
-$478K |
| 2 |
Millennium Management
New York
|
-$48.5K |
| 3 |
BNP Paribas Financial Markets
Paris,
France
|
-$9.91K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$5.64K |
| 5 |
CFM
Catalyst Funds Management
Sydney NSW,
Australia
|
-$4.54K |
RBOT Hedge Fund Activity: Q4 2024 in Review
30 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q4 2024, worth a combined $23.7M — up 126% from $10.4M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of RBOT and 2 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 8 added.
The largest buyer was DnB Asset Management, adding an estimated $38K. The largest seller was DDD Partners, cutting an estimated $478K.
- 30 institutional investors held Vicarious Surgical (RBOT) as of Q4 2024, down from 34 in Q3 2024.
- Funds reported $23.7M of Vicarious Surgical stock for Q4 2024, up 126% quarter-over-quarter.
- 2 funds opened new Vicarious Surgical positions in Q4 2024 and 6 closed out, a net change of -4 holders.
- The largest Vicarious Surgical buyer in Q4 2024 was DnB Asset Management, an estimated $38K added.
- The largest Vicarious Surgical seller in Q4 2024 was DDD Partners, an estimated $478K sold.
Based on aggregated 13F filings for Q4 2024.